Thanks to global research collaborations, the safety and efficacy of APAVAC on pets has been demonstrated. Most of the significant data were published in February 2014 in Clinical Cancer Research.
Very diverse sectors of partners:
In the interests of autonomy of strategic choices, URODELIA wanted to be accompanied by financing health care professionals rather than financial companies. Since its inception, and worldwide, URODELIA has forged close links with various actors of academia and industry leading to the creation of a network of complementary skills.
Whether customers or partners, many companies and organizations trust us from the beginning.
Developed partnerships are of several kinds:
SCIENTIFIC PARTNERS: INSERM and CNRS, CONICET (Argentina)
INDUSTRIAL PARTNERSHIP: ANTELLIS, TBF, GLP, SBM
INSTITUTIONAL PARTNERSHIPS EUROPEAN FRENCH: BPI ; region ; Europe
To protect its structure, patents and industrial property URODELIA relies on recognized firms:
Pinot de Villechenon & Associés, Law Firm
Created in 1979, Villechenon is an established French law firm specialized in business law and is a well-known leader in private equity venture capital transactions. URODELIA finds in its relationship with this company, dynamism, stability and experience. PVA’s involvement alongside URODELIA guarantees expertise, creativity and legal certainty at all stages of its projects.
A firm specialized in industrial property protection: PLASSERAUD. Plasseraud specializes in biotechnology innovation, protection and all operations of the IPs. Plasseraud allows URODELIA to protect its trademarks and inventions and to exploit them and / or have them exploited by third parties.